Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/20861
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKantarcı, Orhun-
dc.contributor.authorSiva, Aksel-
dc.contributor.authorEraksoy, M.-
dc.contributor.authorKarabudak, R.-
dc.contributor.authorSütlaş, Nevin-
dc.contributor.authorAğaoğlu, Jale-
dc.contributor.authorÖzmenoğlu, Mehmet-
dc.contributor.authorToğurul, Erdem-
dc.contributor.authorDemirkıran, Meltem-
dc.date.accessioned2021-06-28T07:29:50Z-
dc.date.available2021-06-28T07:29:50Z-
dc.date.issued1997-
dc.identifier.citationKantarcı, O. vd. (1997). "Survival and predictors of disability in Turkish MS patients". Neurology, 51(3), 765-772.tr_TR
dc.identifier.issn0028-3878-
dc.identifier.urihttps://doi.org/10.1212/WNL.51.3.765-
dc.identifier.urihttps://n.neurology.org/content/51/3/765.short-
dc.identifier.urihttp://hdl.handle.net/11452/20861-
dc.description.abstractObjective: To examine the natural history, survival, and prognostic factors in a sample of Turkish MS patients. Method: This multicenter study included 1,259 definite MS patients diagnosed according to the criteria of Poser et al. Actuarial analysis of selected disability levels of 3, 6, 8, and 10 achieved with the Expanded Disability Status Scale (EDSS); a multivariate Cox regression analysis for prognostic factors related to time to reach EDSS greater than or equal to 6; and Pearson's correlation coefficient for individual factors were performed. Results: The survival (+/- SE) at 15 years from onset was 94.6 +/- 2.9%, and at 25 years was 89.0 +/- 5.8%. The disability reached by 15 years was EDSS greater than or equal to 3 in 66.4%, EDSS greater than or equal to 6 in 41.2%, EDSS greater than or equal to 8 in 10.5%, and EDSS = 10 in 5.4%. The most significant unfavorable prognostic factors were progressive course (relative risk [RR], 3.73; CI, 2.71 to 5.13) and sphincter symptoms at onset (RR, 1.86; CI, 1.23 to 2.82), followed by male sex, motor symptoms at onset, and a high attack frequency within the first 5 years. Primary progressive disease was correlated positively with male sex (r = 0.0895, p = 0.001), older age (I = 0.1807, p = 0.000), and motor (r = 0.1433, p = 0.000) or sphincter symptoms (r = 0.1001, p = 0.000) at onset, unlike relapsing-remitting and secondary progressive disease. Conclusions: Although a slightly better prognosis is observed in the Turkish MS population, early prognostic factors are similar to most of the previous Western series. Primary progressive disease, mostly seen in older men with motor and sphincter involvement at onset, has a worse prognosis and may represent a distinct behavioral variant of MS.en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectProgressive multiple-sclerosisen_US
dc.subjectNatural-historyen_US
dc.subjectPrognostic factorsen_US
dc.subjectStatus scaleen_US
dc.subjectModelsen_US
dc.subjectImpairmenten_US
dc.subjectOnseten_US
dc.subjectNorth-east Scotlanden_US
dc.subjectNeurosciences & neurologyen_US
dc.titleSurvival and predictors of disability in Turkish MS patientsen_US
dc.typeArticleen_US
dc.identifier.wos000075898300024tr_TR
dc.identifier.scopus2-s2.0-0031750982tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.tr_TR
dc.identifier.startpage765tr_TR
dc.identifier.endpage772tr_TR
dc.identifier.volume51tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalNeurologyen_US
dc.contributor.buuauthorTuran, Faruk-
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed9748024tr_TR
dc.subject.wosClinical Neurologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ1en_US
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.